Author Question: Which of the following are inclusion criteria for neonatal ECMO? 1. Reversible lung disease 2. ... (Read 41 times)

Brittanyd9008

  • Hero Member
  • *****
  • Posts: 500
Which of the following are inclusion criteria for neonatal ECMO? 1. Reversible lung disease 2. Gestational age less than 35 weeks 3. Pulmonary barotrauma 4. Persistent acidosis
 
  a. 1 and 3 only
  b. 1, 2, and 3 only
  c. 2 and 4 only
  d. 1, 3, and 4 only

Question 2

What patient population is the only group currently accepted for the use of noninvasive ventila-tion (NIV) in the hospital ward?
 
  a. Chronic obstructive pulmonary disease (COPD) patients with near normal pH
  b. Postoperative patients without pneumonia
  c. No-code patients
  d. Asthma patients with normal SpO2



fauacakatahaias

  • Sr. Member
  • ****
  • Posts: 353
Answer to Question 1

ANS: D
Criteria for patient selection are listed in Box 50-2.

Answer to Question 2

ANS: A
Currently, the only patient population for whom initiation and management of NIV on hospital wards are recommended is hypercapnic COPD patients with a pH of 7.30 or greater.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

For a complete list of videos, visit our video library